Camille Jacques

12PUBLICATIONS
4CO-AUTHORS
Medical virologyEnvironmental epidemiologyMolecular targetsOenology and viticultureGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 26, 2026
In Vitro Effects of the Three Actives IL-12 (5 CH), IFN-γ (6 CH), and TNF-α (5 CH) from the Micro-Immunotherapy Medicine 2LEID-N® on Several Populations of Immune Cells.

|Jun 25, 2026
Perspective: Personalized Management of Oxidative and Nitrosative Stress in Post-Exercise Recovery with a Particular Emphasis on the Potential of Micro-Immunotherapy.

|May 14, 2025
Active Substances from the Micro-Immunotherapy Medicine 2LC1® Show In Vitro Anti-Cancer Properties in Colon, Prostate, and Breast Cancer Models and Immune-Enhancing Capabilities in Human Macrophages.

Camille Jacques, Irene Marchesi, Francesco Paolo Fiorentino

|Mar 26, 2025
Understanding the Mode of Action of Several Active Ingredients from the Micro-Immunotherapy Medicine 2LZONA®.

Camille Jacques, Flora Marchand, Mathias Chatelais

|Apr 13, 2024
The Micro-Immunotherapy Medicine 2LPAPI® Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer Cells.

Camille Jacques, Flora Marchand, Mathias Chatelais

|Mar 28, 2024
In Vitro Study of Interleukin-6 when Used at Low Dose and Ultra-Low Dose in Micro-Immunotherapy.

Camille Jacques, Flora Marchand, Mathias Chatelais

Pageof 2

Frequent Collaborators

12 joint publications

Ilaria Floris

1 joint publications

Francesco Paolo Fiorentino

1 joint publications

Virginie Albinet

1 joint publications

Joana M Buades